Failure to thrive screening: Difference between revisions
Homa Najafi (talk | contribs) Created page with "__NOTOC__ {{Failure to thrive}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the..." |
Homa Najafi (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Failure to thrive}} | {{Failure to thrive}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{Akash}} | ||
==Overview== | ==Overview== | ||
Line 33: | Line 33: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Disease]] | |||
[[Category:Pediatrics]] | |||
[[Category:Neonatology]] |
Revision as of 15:22, 22 August 2020
Failure to thrive Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Failure to thrive screening On the Web |
American Roentgen Ray Society Images of Failure to thrive screening |
Risk calculators and risk factors for Failure to thrive screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]